Nephrogenic Systemic Fibrosis

photoNephrogenic systemic fibrosis, or NSF, is a relatively new disease that experts have linked to the use of gadolinium-based contrast agents—chemical dyes used prior to magnetic resonance imaging (MRI) to enhance results. The Food and Drug Administration first alerted the medical community and public about this link in June 2006, then again in December. In May 2007, the agency asked that the labeling of gadolinium-based MRI dyes be updated to include the risk of nephrogenic systemic fibrosis in patients with kidney disease or insufficiencies.

If you’ve been diagnosed with nephrogenic systemic fibrosis, you should consult with an experienced product liability attorney as soon as possible. Protect your legal rights by contacting us today to arrange a free consultation.

Free NSF Consultation

Gadolinium Attorneys

Makers of defective products deserve to be held accountable for the harm their products cause. By contacting a gadolinium attorney, individuals with nephrogenic systemic fibrosis may be able to hold the makers of gadolinium-based contrast agents responsible for their financial losses and emotional suffering. In cases where NSF results in death, family of the victim may be able to pursue damages on their loved one’s behalf. Recoverable damages often include:

photo
  • Medical bills and related expenses
  • Mental anguish
  • Pain and suffering
  • Loss of companionship
  • Lost income/earning capacity

NSF Gadolinium Attorneys

Gadolinium Contrast Agents Required to Include New Warning

The U.S. Food and Drug Administration (FDA) issued a news release Sept. 9, 2010, requiring that contrast agents containing gadolinium carry a new warning on their labels because it can lead to nephrogenic systemic fibrosis (NSF). Read More »

First Gadolinium Lawsuit Filed in U.S. Court

An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Read More »

Gadolinium-Based MRI Dyes Get Black Box Warning

The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
Read More »